10 Questions in Fabry Disease: An Interactive Infographic Guide to Diagnosis, Monitoring, and Comprehensive Patient Management

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists

0.50 CME CE: Fabry disease CME/CE self-assessment with interactive infographics. Exp 2/28/24

Dialogues about Rett Syndrome: What Patients Wish Clinicians Knew to Enhance Diagnosis

AMA PRA Category 1 Credit(s)^TM

1.00 CME: Panel of neurology and pediatric specialists explore ways to reduce the time to diagnosis by recognizing early signs of Rett syndrome. Exp 8/28/23

Unlocking Movement: Addressing Key Challenges and Strategic Solutions in the Use of Botulinum Toxin for Spasticity and Dystonia

AMA PRA Category 1 Credit(s)^TM

0.75 CME: Faculty highlights the “Top 5” critical issues they see in clinical practice surrounding the use of BoNT therapy for spasticity and dystonia. Exp 9/14/23

Understanding Lysosomal Storage Disorders: From Newborn Screening to Treatments

AMA PRA Category 1 Credit(s)^TM

1.00 CME CE: General characteristics and clinical markers to aid recognition of Lysosomal Storage Disorders and key studies regarding therapy. Exp 12/6/23

Gene Therapy and the Future of DMD Treatment: An EXPLORE™ eLearning Module

AMA PRA Category 1 Credit(s)^TM

1.00 CME: Three different gene therapies are in clinical trials for Duchenne Muscular Dystrophy (DMD). Clinicians need to know the differences and understand the data. Exp 12/13/23

Innovations and Advancements in Duchenne Muscular Dystrophy Management

AMA PRA Category 1 Credit(s)^TM

1.00 CME: Experts from around the world shared the latest developments on management of patients with Duchenne Muscular Dystrophy (DMD) at two recent major conferences. Exp 1/31/24

The New Frontier of Personalized gMG Management: Integrating FcRn Inhibitors Across the Continuum of Care With Point-Counterpoint Case Presentations

AMA PRA Category 1 Credit(s)^TM, CE for Pharmacists

1.00 CME CPE: Myasthenia Gravis: Management With FcRn Inhibitors. The integration of these novel compounds via challenging case studies. Exp 11/22/23

What Can Biomarkers Tell Us? Modern Tools to Assist Navigating Prognosis, Monitoring, and Therapeutic Decision-Making in the Long-Term Management of Multiple Sclerosis

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s)

1.50 CME CE: Experts discuss indicators of MS prognosis and/or disease activity to help clinicians to optimize available tools and strategies. Exp 8/9/23

Fresh Insights From the Alzheimer’s Association International Conference 2022

AMA PRA Category 1 Credit(s)^TM

1.50 CME CE: Learn about scientific advances shared at AAIC 2022 and what they could mean for the future of the early detection and treatment of AD. 9/21/23

Adult Considerations in Spinal Muscular Atrophy: Building Clinician and Patient Medical Teams

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists, AAPA Category 1 CME Credit, ABIM MOC Points

1.00 CME CE: In this educational webcast, expert faculty will discuss treatment needs of adult patients with SMA. Exp 2/15/24

Part 2: Keeping Up With Advances in MS: Cases in Diagnosis and Treatment, A Case-Based Roadmap for Improved Patient Outcomes in Multiple Sclerosis

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s)

1.00 CME CE: Edward Fox, MD, PhD, presents an online learning module that covers key principles in all phases of management for multiple sclerosis. Exp 9/9/23

Clinical Spotlight: Pediatric Diagnosis and Treatment for Rett Syndrome

AMA PRA Category 1 Credit(s)^TM, CNE Contact Hour(s)

1.25 CME CE: Experts discuss emerging therapeutics and important clinical pearls on the burden, screening, and diagnosis of Rett Syndrome. Exp 12/15/23